top of page

INO

Inovio Pharmaceuticals

Price

chg

chg neg

quotes and stock data may be delayed 15 minutes

 My Notes

Only BPIQ Pro members can create company notes. Learn more here.

52 wk low

low api

52 wk hi

high api

Cash

$360.4M

Burn Rate (Qtr)

$61.9M

Mkt Cap

mkt cap api

Avg Volume

volume api

*cash/burn updated:

Q1 '22

Drug Pipeline

Click the button to see the updated pipeline

No drug found

We don't have any drug data for this company yet

Drug | Disease (links)

Stage (next event)

Catalyst Date

Drug Name

Indication

Phase

Event

Exp Date

A free account is required to see the catalyst dates, notes, and more!

Loading Catalysts...

search in progress

Pipeline powered by

INO

BPIQ_Logo_RGB-01.jpg

Company Profile

INOVIO is a biotechnology company committed to powering a new way forward in DNA medicines to save and protect lives worldwide. The company is focused on rapidly bringing to market precisely designed and delivered DNA medicines to potentially treat and protect people from serious and life-threatening diseases associated with HPV, cancer, and infectious diseases.

Recent Posts

See what the community is saying - click to see full post.

NVAX - Buy or sell now with EUA?

INO - Bull Thesis

INO - Bull & Bear Analysis

ASCO 2022 Annual Meeting (American Society of Clinical Oncology) - Clinical Trial Presentations

INO - Bull, Bear, & Amp View

Q4 2021 Run-Up Plays

bottom of page